These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 20220352)
41. COXIBs and non-selective NSAIDs in the gastroenterological setting: what should patients and physicians do? Lazzaroni M; Battocchia A; Bianchi Porro G Dig Liver Dis; 2007 Jun; 39(6):589-96. PubMed ID: 17459794 [TBL] [Abstract][Full Text] [Related]
42. [Nonsteroidal antirheumatic agents--present status and perspectives]. Curković B Reumatizam; 2000; 47(2):7-10. PubMed ID: 11552613 [TBL] [Abstract][Full Text] [Related]
45. Opioids for non-operable osteoarthritis and soft-tissue rheumatism. Dickson DJ Arthritis Res Ther; 2005; 7(5):193-4. PubMed ID: 16207348 [TBL] [Abstract][Full Text] [Related]
46. Cyclo-oxygenase-2 inhibitors : beneficial or detrimental for athletes with acute musculoskeletal injuries? Warden SJ Sports Med; 2005; 35(4):271-83. PubMed ID: 15831058 [TBL] [Abstract][Full Text] [Related]
47. Analgesics and anti-inflammatory medications in sports: use and abuse. Feucht CL; Patel DR Pediatr Clin North Am; 2010 Jun; 57(3):751-74. PubMed ID: 20538155 [TBL] [Abstract][Full Text] [Related]
49. The use of therapeutic medications for soft-tissue injuries in sports medicine. Paoloni JA; Orchard JW Med J Aust; 2005 Oct; 183(7):384-8. PubMed ID: 16201960 [TBL] [Abstract][Full Text] [Related]
50. Relative cardiovascular and gastrointestinal safety of non-selective non-steroidal anti-inflammatory drugs versus cyclo-oxygenase-2 inhibitors: implications for clinical practice. Patrício JP; Barbosa JP; Ramos RM; Antunes NF; de Melo PC Clin Drug Investig; 2013 Mar; 33(3):167-83. PubMed ID: 23338974 [TBL] [Abstract][Full Text] [Related]
53. [Pain treatment with traditional NSAR and coxibs: an interdisciplinary assessment]. Fischbach W; Baerwald C; Darius H; Gross M; Nickenig G; Nüßlein H; Stichtenoth DO Dtsch Med Wochenschr; 2013 Jan; 138(3):91-6. PubMed ID: 23299345 [No Abstract] [Full Text] [Related]
55. [Pain killers--killing the pain or the patient?]. Zellweger MJ; Pfisterer ME Praxis (Bern 1994); 2006 Feb; 95(8):273-6. PubMed ID: 16523991 [TBL] [Abstract][Full Text] [Related]
56. Prophylactic use of NSAIDs by athletes: a risk/benefit assessment. Warden SJ Phys Sportsmed; 2010 Apr; 38(1):132-8. PubMed ID: 20424410 [TBL] [Abstract][Full Text] [Related]
57. Use of NSAIDs in triathletes: prevalence, level of awareness and reasons for use. Gorski T; Cadore EL; Pinto SS; da Silva EM; Correa CS; Beltrami FG; Kruel LF Br J Sports Med; 2011 Feb; 45(2):85-90. PubMed ID: 19666628 [TBL] [Abstract][Full Text] [Related]
58. Nonopioid analgesics. Munir MA; Enany N; Zhang JM Med Clin North Am; 2007 Jan; 91(1):97-111. PubMed ID: 17164106 [TBL] [Abstract][Full Text] [Related]
59. Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. Harirforoosh S; Asghar W; Jamali F J Pharm Pharm Sci; 2013; 16(5):821-47. PubMed ID: 24393558 [TBL] [Abstract][Full Text] [Related]
60. Update on the use of cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs in horses. Ziegler A; Fogle C; Blikslager A J Am Vet Med Assoc; 2017 Jun; 250(11):1271-1274. PubMed ID: 28509650 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]